Provided by Tiger Trade Technology Pte. Ltd.

HCW Biologics Inc.

0.7385
-0.0140-1.86%
Post-market: 0.6775-0.0610-8.26%19:59 EDT
Volume:1.16M
Turnover:855.62K
Market Cap:2.60M
PE:-0.05
High:0.7888
Open:0.7258
Low:0.7000
Close:0.7525
52wk High:17.80
52wk Low:0.4717
Shares:3.52M
Float Shares:2.88M
Volume Ratio:0.01
T/O Rate:40.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.8100
EPS(LYR):-30.9580
ROE:-27725.96%
ROA:-31.66%
PB:-1.23
PE(LYR):-0.02

Loading ...

Analysts Offer Insights on Healthcare Companies: XOMA Royalty Corporation (XOMA) and HCW Biologics (HCWB)

TIPRANKS
·
Mar 19

3 Penny Stocks to Watch Now, 3/17/26

TIPRANKS
·
Mar 17

BRIEF-Hcw Biologics Closes Exclusive Worldwide License For Hcw11-006 – A High Potential Fusion Immunotherapeutic

Reuters
·
Mar 17

HCW Biologics Inc - Has Free Option to Reclaim Americas Rights

THOMSON REUTERS
·
Mar 17

BUZZ-U.S. STOCKS ON THE MOVE-Customers Bancorp, Forgent Power Solutions, Nvidia

Reuters
·
Mar 17

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:43 PM

Reuters
·
Mar 17

BUZZ-U.S. STOCKS ON THE MOVE-Dollar Tree, Micron, Customers Bancorp

Reuters
·
Mar 16

HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances

GlobeNewswire
·
Mar 16

HCW Biologics Inc Announces Special Stockholder Meeting

Reuters
·
Mar 04

HCW Biologics regains compliance with continued listing rules for Nasdaq

TIPRANKS
·
Mar 02

HCW Biologics Regains Nasdaq Listing Compliance, Faces Ongoing Oversight

TIPRANKS
·
Mar 02

BRIEF-HCW Biologics Regains Compliance With All Continued Listing Rules For Nasdaq Per Nasdaq Determination Letter

Reuters
·
Mar 02

Nasdaq Panel Restores HCW Biologics’ Listing Compliance

Reuters
·
Mar 02

HCW Biologics Prices $1.5 Million Offering With Warrants at $0.6055 Per Share

Reuters
·
Feb 18

HCW Biologics Announces Pricing of $1.5 Million Follow-on Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Feb 18

Press Release: HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

Dow Jones
·
Feb 18

HCW Biologics Licenses TRBC Asset to China JV Trimmune

TIPRANKS
·
Feb 13

HCW Biologics, WY Biotech close first round of financing for joint venture

TIPRANKS
·
Feb 13

HCW Biologics and Wy Biotech Announce Closing of First Round of Financing for Newly Formed Joint Venture Trimmune

THOMSON REUTERS
·
Feb 13

Press Release: HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune

Dow Jones
·
Feb 13